CEO Pascal Soriot via Getty Images

As­traZeneca's jug­ger­naut PARP play­er Lyn­parza scoops up an­oth­er dom­i­nant win in PhI­II as the FDA adds a 'break­through' for Calquence

As­traZeneca’s on­col­o­gy R&D group un­der José Basel­ga keeps churn­ing out hits.

Wednes­day morn­ing the phar­ma gi­ant and their part­ners at Mer­ck part­ed the cur­tains on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.